Oncostatin M Receptor Antikörper (N-Term)
Kurzübersicht für Oncostatin M Receptor Antikörper (N-Term) (ABIN635957)
Target
Alle Oncostatin M Receptor (OSMR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- OSMR antibody was raised against the N terminal of OSMR
-
Aufreinigung
- Affinity purified
-
Immunogen
- OSMR antibody was raised using the N terminal of OSMR corresponding to a region with amino acids YQSEVLAERLPLTPVSLKVSTNSTRQSLHLQWTVHNLPYHQELKMVFQIQ
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
OSMR Blocking Peptide, (ABIN936190), is also available for use as a blocking control in assays to test for specificity of this OSMR antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of OSMR antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Oncostatin M Receptor (OSMR)
-
Andere Bezeichnung
- OSMR
-
Hintergrund
- Oncostatin M is a member of the IL6 family of cytokines. Functional receptors for IL6 family cytokines are multisubunit complexes involving members of the hematopoietin receptor superfamily. Many IL6 cytokines utilize gp130 as a common receptor subunit. OSM binds to the gp130 receptor subunit and, in association with the leukemia inhibitory factor receptor, induces a proliferative response in permissive cells.
-
Molekulargewicht
- 110 kDa (MW of target protein)
-
Pathways
- JAK-STAT Signalweg, Growth Factor Binding
Target
-